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Background: The aim of this study was to investigate the frequency of chronic venous disorders (CVD) in different
demographic groups in Italy and to provide correlations between patterns of valve incompetence and clinical feature of
disease severity.
Methods: Advertisements in television and newspapers in 53 Italian cities were used to solicit 16,251 subjects (13,826
women, mean age 50.4 years; 2,425 men, mean age 59.1 years). They underwent a clinical examination of the lower limbs,
including presence and severity of visible signs (CEAP classification), and assessment of functional disease by color-coded
duplex ultrasound imaging.
Results: Varicose veins and telangiectases were the most common objective signs in both men and women. Older people
were more severely affected. Telangiectases were more frequent in women, and men had a higher incidence of trunk
varices, trophic changes, and venous reflux. Frequency of both visible and functional venous disease increased with family
history and body mass index. Presence of reflux correlated positively with increasing CEAP grade of visible disease (P for
trend < .0001 for all superficial venous segments). A large number of subjects, especially women, complained of
subjective symptoms in the legs, and the presence of symptoms correlated almost always positively with both worsening
of visible findings (P for trend < .001) and presence of hemodynamic change in both genders.
Conclusions: The frequency of reflux increased with the severity of visible signs of disease as described by the CEAP
classification. In men, the occurrence of subjective symptoms was mostly correlated with functional disorders. ( J Vasc
Surg 2007;46:322-30.)Chronic venous disorders (CVD) is a common condi-
tion that changes dynamically in the adult population.1-5
Pharmaceutic or surgical intervention may delay disease
progression, but unfortunately, many individuals with
CVD are referred to medical treatment too late, only after
tissue changes have already started. In such cases, interven-
tion is difficult and frequently unsuccessful.6 The prognos-
tic value of early, clinically detectable, pathologic changes
associated with patterns of valve insufficiency is still unclear.
Several studies have shown a correlation between clinical
severity of venous disease and the extent of superficial and
deep venous incompetence.7,8 These investigations, how-
ever, have focused on patients with CVD who had been
referred to specialist clinics and not on a more general
population.
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322Recently, we reported the results of a large epidemio-
logic nationwide survey done in 2003 in Italy as a part of a
CVD prevention program in which 5000 individuals in
three arbitrarily defined geographical regions of Italy vol-
untarily enrolled.9-11 The results of the survey allowed us to
predict a geographic distribution of CVD-related abnor-
malities in the general population as detected by color-
coded duplex ultrasound imaging.
Although our previous study was based on an already
large sample size, some questions remained unanswered
because we did not consider a number of factors that were
subsequently found to be relevant to establish correlations
between visible signs of the disease and its functional ex-
pression.10,11 Thus, we designed this new survey to collect
data on the presence or absence of correlations between
patterns of valve incompetence and CVD severity in a very
large population of Italian subjects.
METHODS
Participants. The survey was conducted in Italy be-
tween May and July 2004 as a part of a CVD prevention
program organized by the Scientific Institute Hospital San
Raffaele in Milan. A large cross-sectional, nonrandom sam-
ple of women and men was to be recruited throughout
Italy, selected by means of advertising in television, news-
papers, and leaflets distributed by a press agency. The
advertising addressed explicitly people who claimed to have
CVD. All subjects were recruited on a spontaneous and
voluntary basis, and could schedule, through a call center or
with th
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included a color-coded duplex ultrasound imaging.
Men and women aged 18 to 89 years who responded
were contacted. Those who agreed to participate were
invited for a medical ambulatory examination at the partic-
ipating hospitals or in a specially equipped mobile unit, in
which they underwent all diagnostic procedures. A total
sample size of 20,000 participants was foreseen, based on
the time needed for an accurate clinical examination of each
subject and in accordance with the number of visits planned
for each unit in operation.
Fifty-three vascular surgery units distributed through-
out the nation participated in the study. The physicians
were all vascular surgeons experienced with Doppler ultra-
sound imaging. Methods and questionnaires were stan-
dardized across centers and followed a protocol from the
recommendations issued by the Italian Society of Vascular
andEndovascular Surgery.Data qualitywas assuredby regular
checks of the data collected by the study coordinators.
Procedures. At the study visit, the examining physi-
cian gathered detailed information on demographics (age,
sex, pregnancies, height, and weight), lifestyle (physical
activity and smoking habit), and contraceptive use. Family
history of varicose veins was restricted to first-degree rela-
Table I. Percentage of occurrence of objective signs of ch
sex, age, family history, and body mass index using the CE
Study group
(n  1651)
C0
No signs
(n  3392)
C1
Telangiectasia
(n  10,679)
% % %
Total of
population* 100.0 20.9 65.7
Sex†
Male 14.9 34.9 36.5
Female‡ 85.1 18.4 70.8
No pregnancies 28.9 29.0 60.5
1 pregnancy 71.1 14.2 74.7
Age§
30 8.3 39.3 50.4
30-49 34.2 22.4 66.2
50 57.5 17.3 67.6
Family history
Yes 66.7 18.5 68.2
No 33.3 24.4 62.0
Body mass index¶
20 11.2 28.0 64.6
21-26 55.6 20.8 66.6
27-32 28.4 18.9 64.9
33 4.8 15.2 64.8
*Percentages do not always add to 100, as some patients are assigned to m
†Differences between male and female all statistically significant, P  .001,
‡Differences between no pregnancies and 1 pregnancies all statistically sig
§Age groups all statistically significantly different, P  .001.
Family history of chronic venous disease: two subgroups statistically signifi
eczema/skin changes (P  .21, NS), and C5-6, ulcers (P  .71, NS).
¶All body mass index groups statistically significantly different (P  .001),tives and was obtained directly from the subjects (familymembers were not examined). Specific medical questions
included history of deep thrombotic events, leg arteriopa-
thy, hemorrhoids, and varicocele. A detailed physical exam-
ination was performed by a trained vascular surgeon to
assess visible signs of venous disease, including telangiecta-
ses, varicose veins, edema, trophic changes, and ulcers.
Signs were classified according to the CEAP clinical classi-
fication:
● C0, no visible or palpable signs of venous disease;
● C1, telangiectases or reticular veins;
● C2, varicose veins;
● C3, edema;
● C4a, pigmentation or eczema;
● C4b, lipodermatosclerosis or atrophie blanche;
● C5, healed venous ulcer; and
● C6, active venous ulcer.
12
Classification of visible signs of the disease was made
before and thus independently of duplex ultrasound imag-
ing. Patients with varices in the extrasaphenous veins were
allocated to group C2 (Table I), whereas patients who had
reflux in nonsaphenous veins, such as the vulvar and gluteal
veins, or those in the lateral thigh and absence of reflux in
saphenous veins were considered functionally normal for
venous disorders in the population studied according to
linical classification
C2 Varicoses
C3
Edema
(n  2251)
C4a,4b
Eczema/skin
changes
(n  1444)
C5-6
Ulcers
(n  63)
t saphenous
vein
 5863)
Saphenous
vein
(n  3204)
% % % % %
36.1 19.7 13.9 8.9 0.4
39.8 26.4 14.1 12.4 0.7
35.4 18.5 13.8 8.3 0.3
22.8 9.8 10.3 4.1 0.2
40.6 22.2 15.2 10.0 0.4
16.2 4.8 8.7 1.4 0.0
29.8 13.9 10.3 4.4 0.1
42.6 25.3 16.7 12.7 0.6
38.1 21.0 14.0 8.7 0.4
32.3 17.4 13.5 9.3 0.4
23.0 10.5 5.7 3.3 0.1
34.3 17.8 11.0 7.0 0.2
42.8 25.4 19.3 12.7 0.6
47.3 28.5 33.4 22.1 1.1
an one CEAP category.
he exception of C3, edema (P  .745, NS) and C5-6, ulcers (P  .024).
t, P  .001, with the exception of C5-6, ulcers (P  .034).
different (P  .001), with the exception of C3, edema (P  .36, NS), C4,
e exception of C1, telangiectasia (P  .12, NS).ronic
AP c
No
(n
ore th
with t
nifican
cantlythe purpose of this survey.
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tion of CVD-related lower limb symptoms commonly
present just in the early stages of the pathology such as
heavy/tired legs, pain, and swollen leg.12
Color-coded duplex ultrasound imaging was used to
collect information on the presence or absence of func-
tional hemodynamic disturbances in the superficial venous
system. We therefore only collected hemodynamic data for
the saphenofemoral junction (SFJ), the great saphenous
vein (GSV) over the length of the whole leg, and the
saphenopopliteal junction (SPJ). Appropriate probes were
selected according to the depth of the vessels examined
(convex 2-MHz to 5-MHz probes or linear 5-MHz to
12-MHz probes).
Subjects underwent duplex examination standing in
full erect posture. For the examination of the thigh, sub-
jects flexed the leg slightly at the knee and transferred the
body weight on the other leg. The examinations were
performed using calf manual compression-release to pro-
voke superficial venous reflux. The beginning and the end
of the period of reflux was identified. Normal reflux was
defined as 500 milliseconds of reverse flow.13 A reflux
time of 500 milliseconds in the GSV, SFJ, or SPJ was
considered superficial functional disease. There were no
therapeutic interventions in this study.
Statistical analysis. Information from case report
forms and questionnaires was made anonymous, tracked,
and collected in an Excel database (Microsoft Inc, Red-
mond, Wash), checked for accuracy of input and reliability,
and then transferred into SAS 8.02 software (SAS Institute,
Inc, Cary, NC) for subsequent statistical analysis.
Differences between continuous variables were tested
using the Student t test for independent groups, and cate-
goric differences were tested with the 2 statistics and the
Cochran-Armitage trend test. No adjustments were made
for multiple comparisons because this survey had no con-
firmatory character.
In the case of patients reporting symptoms and having
signs on both legs, the presence of reflux was not analyzed
separately for each leg, but data derived from the more
affected leg were analyzed. The correlation between the
presence of visible signs of disease (CEAP classification) or
self-assessed subjective leg symptoms with an abnormal
reflux was assessed separately for each of the three vein
segments of the superficial venous network. Because gen-
der appeared to be a significant covariate for almost all
objective signs of CVD, the degree of correlation between
visible signs of the disease and functional disease was eval-
uated separately by sex.
RESULTS
The survey included 18,560 subjects living in the urban
area of 53 large towns in Italy. A total of 16,251 subjects
were evaluable, consisting of 13,826 women (mean age,
50.4 years) and 2425 men (mean age, 59.1 years). Ex-
cluded were 2075 subjects for whom data for objective
symptoms were incomplete and 234 for whom age, weight,
or height was not available. More women (85.1%) thanmen (14.9%) were enrolled in the survey. Complete duplex
scans were available for 12,496 subjects (10,377 women,
2119 men).
Frequency of visible and functional signs of chronic
venous disease. Table I summarizes the frequency of vis-
ible signs of CVD (CEAP classification) in each demo-
graphic group of the study population. Overall, physical
examination of the legs showed that about one fifth of the
subjects examined were free of visible signs of CVD (Table I).
Men were twice as likely as women to have symptomless
legs (34.9% vs 18.4%, P  .001). A small number of
respondents had a history of arteriopathy (women, 0.96%;
men, 5.53%), and an even smaller proportion had a history
of thrombosis (women, 1.33%; men, 1.77%). We did not
examine separately the patients who underwent any kind of
previous surgery, including endovenous ablation or sclero-
therapy.
Telangiectases were very widespread in most subjects,
but mainly in women. Men, however, appeared to have a
consistently, and statistically significantly, higher incidence
of varicose veins than women (P  .0001 for both trunk
and extrasaphenous varicose veins).
No differences were found in the frequency of edema
between the two genders, but trophic changes, including
ulcers, were nearly three times as common in men than in
childless women. Pregnancies were clearly related to an
increase of the major visible signs of the disease, increasing
monotonically with increasing number of pregnancies (Fig 1).
An age-dependent, linear increase in edema, varicose
veins, and trophic changes could be observed, with subjects
aged 50 being almost five times as likely to show trunk
varicoses than the younger respondents in the survey. The
frequency of venous ulcers increased rapidly from 0.1%
before age 50, to 0.6% at age 50. A similar picture could
be seen for telangiectases. The frequency of telangiectases
and varicose veins was higher when a family history of the
disease was reported. In both sexes, bodymass index (BMI)
was positively and statistically significantly correlated with
visible signs of CVD, telangiectases being the only excep-
tion.
More than 40% of the study population showed some
degree of superficial venous incompetence at the duplex
examination (Table II). Men were more severely affected
than women (48.3% vs 33.0% of women with no previous
pregnancy, P  .001). Less than 25% of the men and
women in the age class 30 showed some degree of
superficial functional disease. The percentage of hemody-
namic disturbances then increased quite rapidly with age,
and reflux could be seen in approximately 50% of the
population aged50 years old. In the patients with CEAP
4 to 6, only 20.9% of the men and 29.1% of the women had
no reflux (Table III). The frequency of reflux increased
monotonically with body weight from 33.3% for BMI20
to 55.3% for BMI 33 (P  .001) and was also positively
related to a family history of venous disease (P  .001).
Most of the respondents in the survey complained of
some symptoms, women havingmore complaints thanmen
(P  .0001). The most relevant symptoms were tired,
nous
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80% of the women (Table IV). All symptoms tended to
increase with increasing BMI (P  .001).
Correlation of clinical signs with color-coded du-
plex ultrasound imaging. The relation between CEAP
grade and functional disease or subjective leg symptoms
was assessed using the Cochran-Armitage test for linear
trend. Table III summarizes the overall results of the du-
plex scan performed on 12,496 subjects. Overall, approxi-
mately 80% of functionally healthy legs had no visible CVD
signs. Conversely, among subjects with functional disease,
no visible signs of CVD were detected in 10% of cases, and
nearly half of the legs with spider veins were functionally
normal (Table III). In the subgroup with overt CVD signs
and abnormal venous function, worsening of CVD was
associated with an increasing frequency of reflux (P value
for trend  .001 for all superficial venous segments). This
relationship was seen in both sexes but was more evident in
men than in women, with the exception of CEAP C0 (Fig 2).
The men in the study had significantly less telangiecta-
ses than the women, but the superficial venous incompe-
tence in presence of this visible sign was twice as frequent in
men as in women. The difference between the genders, as
Fig 1. Percentage of occurrence of signs of chronic ve
number of pregnancies.for the correlation between visible signs and functionaldisorder, became less evident as the disease worsened. For
legs with superficial functional disease of the GSV level, the
sex-adjusted frequency of edema was 59% in men and 44%
in women compared with 28% and 39%, respectively, for
functionally normal legs.
A correlation between reflux and presence of subjective
symptoms in the legs could also be seen (Table V). Symp-
toms were less frequent in the men but were more fre-
quently related to hemodynamic disturbances than in the
women.
The frequency of subjective symptoms is presented in
Table VI. Lower limb symptoms such as heaviness, pain,
and feeling of swelling were very common in the general
population independently of the presence or absence of
visible signs of the disease. Symptoms were more frequent
in women, but their frequency correlated positively in both
genders with the CEAP grade (P value for trend .001 for
all symptoms with the exception of pain, for which no
significant correlation could be seen in the men).
DISCUSSION
This survey confirms that CVD is very common in Italy,
with approximately one fifth of the study population show-
disorders in the study population according to sex anding trunk varicose veins.8 Venous incompetence increases
SFJ, Saphenofemoral junction; GSV, great saphenous vein; SPJ, saphenopopliteal junction.
*Values of P 2 square test for independence were all .001.
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subjects with complete scans)
Visible signs of disease*
P
C0 C1 C2 C3 C4-6
No. (%) No. (%) No. (%) No. (%) No.(%)
Functional disease†
No reflux (n  7111)
Male 611 (81.9) 324 (42.0) 222 (22.0) 83 (28.0) 53 (20.9) .001
Female 1562 (76.9) 4102 (56.9) 1288 (30.8) 546 (38.7) 233 (29.1) .001
Presence of reflux (n  5385)
Male 135 (18.1) 447 (58.0) 789 (78.0) 213 (72.0) 201 (79.1) .001
Female 469 (23.1) 3107 (43.1) 2892 (69.2) 866 (61.3) 567 (70.9) .001
Segments‡
SFJ
Male 67 (9.2) 306 (42.1) 533 (56.9) 149 (55.4) 140 (61.1) .001
Female 212 (10.7) 1849 (27.0) 1930 (50.6) 563 (43.5) 397 (54.7) .001
GSV
Male 65 (9.0) 325 (45.2) 586 (63.5) 156 (59.1) 153 (67.7) .001
Female 208 (11.0) 1936 (29.1) 2015 (54.4) 550 (43.9) 393 (55.6) .001
SPJ
Male 44 (6.0) 179 (23.7) 325 (33.2) 95 (34.3) 95 (39.4) .001
Female 114 (6.0) 1028 (14.9) 1009 (25.5) 373 (28.3) 258 (34.1) .001
C0, No signs; C1, telangiectasis; C2, varicose veins; C3, edema; C4-6, eczema, skin changes, ulcers; SFJ, saphenofemoral junction; GSV, great saphenous vein;
SPJ, saphenopopliteal junction.
*Percentages do not add to 100% because when several visible signs were present at the same time in a given subject, every single sign was analyzed separately.
Single cases of visible disease expressed as percentage of total sample (N  12,461, 100%) were as follows: C1, 4698 (37.7%); C2, 333 (10.7%); C3, 274
(22.0%); C4-6, 50 (0.4%); C1  C2, 439 (27.6%); C1  C3, 449 (3.6%); C1  C4-6, 187 (1.5%); C1  C2  C3, 660 (5.3%); C1  C2  C4-6, 474 (3.8%);
C1  C3  C4-6, 75 (0.6%); C2  C3, 199 (1.6%); C2  C4-6, 112 (0.9%); C2  C3  C4-6, 100 (0.8%); C3  C4-6, 37 (0.3%); C1  C2  C3  C4-6, 374
(3.0%).
†Data from both legs were pooled.
‡Percentages do not add to 100% because if more than one vein segment of the superficial venous network was affected in a given subject, the presence of eachTable II. Percentage of occurrence of venous reflux in the population studied according to sex, age, family history, and
body mass index (12,496 subjects with complete scans)
Reflux
No reflux
(n  7111)
Right SFJ
(n  2526)
Right GSV
(n  2639)
Right SPJ
(n  1413)
Left SFJ
(n  2533)
Left GSV
(n  2612)
Left SPJ
(n  1453)
% % % % % % %
Total population* 56.9 20.2 21.1 11.3 20.3 20.9 11.6
Sex
Men 51.7 24.2 26.3 14.9 24.5 26.3 15.9
Women 58.0 19.4 20.1 10.6 19.4 19.8 10.8
No pregnancies 67.1 13.5 12.8 8.2 13.3 13.0 8.1
1 pregnancy 54.2 21.9 23.1 11.7 22.0 22.6 12.1
Age*
30 77.4 9.9 8.3 6.5 8.3 8.1 6.8
30-49 63.6 15.8 16.2 8.9 16.3 16.7 9.2
50 50.5 24.0 25.5 13.3 24.1 25.0 13.6
Family history*
Yes 55.2 21.1 21.7 11.9 21.6 22.0 12.0
No 60.4 18.7 19.9 10.4 18.4 19.4 11.2
Body mass index*
20 68.7 14.0 14.2 7.1 11.5 11.8 7.1
21-26 59.0 17.7 19.2 10.6 18.4 19.1 11.1
27-32 50.2 25.5 25.8 12.9 25.1 25.6 13.4
33 44.7 31.1 29.5 18.8 32.6 34.4 17.7single visible sign of the disease was analyzed separately for each of the three vein segments.
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number of pregnancies in women help to induce or aggra-
vate CVD. In previous studies, obesity has been reported to
be a risk factor for varicose veins.14,15 Correspondingly, we
detected a statistically significant positive association be-
tween BMI or family history of CVD and frequency of
venous disease. Large BMI values, and therefore over-
weight, are risk factors for CVD. The correlation with
family history must be interpreted with caution, however,
because family history from self-reporting is likely to be
biased, and the study was not planned to specifically study
this aspect of the disease.
Approximately 80% of subjects with no visible signs of
venous disease but complaining of subjective symptoms
had functionally healthy legs. When visible signs of disease
were seen, the frequency of valve incompetence correlated
positively with worsening of symptoms. Spider and reticu-
lar veins, therefore, could be early and easily detectable
alarm symptoms that may help to timely refer patients to
medical care, with subsequent monitoring of the progress
of the disease that could allow the physicians to start
therapy before more serious stages of CVD set in.
Because varicose veins were associated with incompe-
tence in the superficial venous system in approximately 80%
of the subjects, a good therapeutic outcome could be
expected from surgery on the superficial veins in these
patients. The other 20%, represented by subjects with
varicoses other than of the saphenous vein, could also
benefit by the treatment of varicoses without any interven-
tion on the saphenous vein.
Subjects with edema but otherwise functionally normal
legs were also frequent in this survey. These patients prob-
ably had deep venous or nonvenous problems that could
Table IV. Percentage of occurrence of subjective leg symp
history and body mass index
Study group
(n  16,251)
No symptoms
(n  1711)
% % P*
Sex
Men 14.9 17.1 .001
Women 85.1 9.4
No pregnancies 28.9 11.2 .001
1 pregnancy 71.1 8.7
Age
30 8.3 11.1 .038
30-49 34.2 9.7
50 57.5 11.0
Family history
Yes 33.3 8.7 .001
No 66.7 11.2
Body mass index
20 11.2 12.0 .001
21-26 55.6 11.4
27-32 28.4 9.3
33 4.8 3.4
*P values: 2 test for independence.have accounted for their CVD symptoms. This study didnot undertake duplex scanning of deep vein segments, and
therefore, we cannot exclude deep venous incompetence.
In addition, we did not study the osteoarticular system
and therefore cannot exclude that some of the symptoms
referred were actually derived from joint problems. The
gender-related patterns in the frequency of edema in both
functionally diseased and normal legs observed in the
present study suggest that the higher proportion of edem-
atous legs in women is probably of nonvenous etiology.
Conversely, only few cases of functionally diseased legs did
not show any visible signs of the disease.
The correlation between visible and functional disease
appears to be higher in men than in women, especially for
milder forms. Mild signs of venous disease, such as telangi-
ectases, are much more frequent in women than in men,
but telangiectases are associated with a functional disorder
twice as frequently in men than in women. The difference
between the two sexes becomes less evident with the wors-
ening of the disease. The larger degree of overlapping
between visible findings and venous incompetence in men
was not a surprising finding in this study, because we had
already observed it11 and is in good agreement with find-
ings from other randomized epidemiologic studies con-
ducted in Western European countries.16,17
According to this survey, symptoms such as heaviness,
pain, and the feeling of swelling in the legs cannot be
considered necessarily an alarm bell for objective venous
disease. Even if we could observe an apparently strong
positive correlation between symptoms in the legs and the
worsening of clinically diagnosed CVD, many subjects,
especially young people with no diagnose of reflux or CVD
abnormality, self-reported a whole range of venous symp-
toms in the lower limbs. The correlation between symp-
s in the population studied according to sex, age, family
Tired/heavy legs
(12,548)
Pain
(n  8968)
Swollen legs
(n  8801)
% P % P % P
6.8 .001 49.6 .001 39.1 .001
9.0 56.2 56.8
8.2 .22 50.4 .001 57.5 .001
9.2 NS 58.5 56.3
8.7 .001 50.7 .001 57.0 .001
9.9 53.1 56.0
5.4 57.1 52.7
9.2 .001 58.5 .001 56.3 .001
8.2 50.4 57.5
7.2 .001 49.8 .001 46.7 .001
6.3 52.5 51.0
8.2 60.0 58.9
3.0 68.1 79.0tom
6
7
7
7
7
7
7
7
7
7
7
7
8toms (especially pain in the legs) and visible signs of the
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The 10% difference in aching complaints between subjects
with normal legs and those with skin changes seems to be of
limited clinical value. In men, aching legs were rather
Fig 2. Percentage of the respond
Table V. Prevalence of venous reflux in the population stu
subjects with complete scans)
No symptoms
No. % N
Functional disease†
No reflux (n  7111)
Male 207 58.3
Female 579 64.1 4
Presence of reflux (n  5385)
Male 148 41.7
Female 324 35.9 3
Segments‡
SFJ
Male 97 28.1
Female 184 21.3 2
GSV
Male 100 29.4
Female 190 22.8 2
SPJ
Male 54 15.7
Female 92 10.8 1
SFJ, Saphenofemoral Junction; GSV, great saphenous vein; SPJ, Saphenopo
*Percentages do not add to 100% because when several leg symptoms wer
separately.
†Data from both legs were pooled.
‡Percentages do not add to 100% because if more than one vein segment of t
single leg symptom was analyzed separately for each of the three vein segmcorrelated with the presence of a superficial functionaldisorder, although we observed no significant relationship
between pain and severity of visible symptoms in this sub-
sample.
The major strengths of this survey are the large sample
ith reflux according to their sex.
in relation to the subjective leg symptoms (12,496
Subjective symptoms in the legs*
/heavy legs Pain Swollen legs
% No. % No. %
49.6 544 51.3 349 42.7
56.8 3238 54.5 3249 55.4
50.4 516 48.7 469 57.3
43.2 2702 45.5 2618 44.6
34.5 340 33.8 311 41.0
27.0 1625 29.0 1577 28.4
36.9 370 37.0 322 43.0
28.8 1702 31.3 1630 30.3
20.8 206 19.9 187 23.7
14.7 878 15.6 880 15.8
junction.
ent at the same time in a given subject, each single symptom was analyzed
erficial venous network was affected in a given subject, the presence of eachdied
Tired
o.
709
720
720
592
466
134
494
194
290
152
pliteal
e presstudied and the use of an objective measurement tool such
resent
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Volume 46, Number 2 Chiesa et al 329as the Doppler ultrasound imaging, as well as the coordi-
nated and standardized data collection. Our study, how-
ever, suffers from some limitations. The results of our
survey must be put in perspective, because mass advertising
has most likely biased the inclusion of subjects toward those
people who had some sort of subjective leg symptoms or
who were interested in a free medical visit. For example, we
cannot exclude that gender differences may be due in part
to a difference in awareness of lower limb symptoms be-
tween the sexes, as suggested by the higher voluntary
participation by women compared with men. In addition,
the symptoms questionnaire used had to be as short and
compact as possible. The use of a validated quality-of-life
questionnaire might have yielded more accurate results.
Because of the large number of subjects included in the
survey in a very short time, no stringent quality assurance of
the data collection could be implemented, and this is
reflected in the large number subjects whose data were not
evaluable. The data collection included medical history of
venous diseases but was not designed to collect detailed
information on patients who underwent any kind of previ-
ous surgery (including endovenous ablation or sclerother-
apy) and these patients could not be analyzed separately.
Finally, Doppler ultrasound imaging was limited in
extent to superficial venous systems, and this may have led
to some underestimation of the frequency of CVD in the
population studied. This notwithstanding, the data re-
ported here confirm on a large scale those already collected
in previous research.4,5,9,14-16
CONCLUSIONS
This survey has analyzed a very large sample of respon-
dents. Even if patients voluntarily responded to the screen-
Table VI. Prevalence of leg symptoms in the population stud
Leg symptoms
Visi
C0 C1
No. (%) No. (%)
No symptoms
Male 169 (20.0) 130 (14.7)
Female 294 (11.5) 868 (8.9)
Symptoms†
Male 677 (80.0) 756 (85.3)
Female 2252 (88.5) 8925 (91.1)
Tired/heavy legs
Male 540 (63.9) 620 (70.1)
Female 1917 (75.3) 7849 (80.2)
Pain
Male 413 (48.9) 454 (51.3)
Female 1375 (54.0) 5535 (56.5)
Swollen legs
Male 240 (28.4) 396 (44.7)
Female 1362 (53.5) 5593 (57.1)
C0, No signs; C1, telangiectasia; C2, varicose veins; C3, edema; C4-6, eczem
*Percentages do not add to 100% because when several visible signs of disea
separately.
†Percentages do not add to 100% because if more than one symptom was p
for each leg symptom.ing and the study cannot be thus considered a classicepidemiologic analysis, we have observed a number of
correlations that are either new or at least partly confirm
already published data. We have seen a clear association
between BMI or family history of CVD and other venous
disorders. The frequency of valve incompetence increases
with worsening of visible findings of the disease, becoming
large at age 50 years and increasing monotonically with
the number of pregnancies in women. Although the corre-
lation between subjective symptoms and visible findings
was more evident in women, the occurrence of legs symp-
toms in men frequently reflected a functional venous disor-
der. Also striking in this study is the high percentage of
those subjects with symptoms and signs, such as edema,
who had no venous abnormality and vice versa. This is
important information showing that these so-called mark-
ers of chronic venous disorders may be present without
venous disease and that they can also commonly be absent
when the disease is present.
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